1. Home
  2. COEP vs SST Comparison

COEP vs SST Comparison

Compare COEP & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$12.00

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

Logo System1 Inc.

SST

System1 Inc.

HOLD

Current Price

$1.84

Market Cap

27.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
COEP
SST
Founded
2017
2013
Country
United States
United States
Employees
7
300
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
27.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
COEP
SST
Price
$12.00
$1.84
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
33.4K
16.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.32
$0.29
52 Week High
$21.41
$11.30

Technical Indicators

Market Signals
Indicator
COEP
SST
Relative Strength Index (RSI) 45.04 19.26
Support Level $11.76 $0.34
Resistance Level $13.23 $4.61
Average True Range (ATR) 0.90 0.32
MACD 0.05 -0.10
Stochastic Oscillator 38.21 12.96

Price Performance

Historical Comparison
COEP
SST

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About SST System1 Inc.

System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.

Share on Social Networks: